Skip to main content

Main menu

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI

User menu

  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Journal of Nuclear Medicine
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Journal of Nuclear Medicine

Advanced Search

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • View or Listen to JNM Podcast
  • Visit JNM on Facebook
  • Join JNM on LinkedIn
  • Follow JNM on Twitter
  • Subscribe to our RSS feeds
Meeting ReportRadiopharmaceutical Chemistry: New Radiopharmaceuticals-Broader/General Applications

Microfluidic synthesis of [18F]FMISO

Thomas Collier, Murthy Akula and George Kabalka
Journal of Nuclear Medicine May 2010, 51 (supplement 2) 1462;
Thomas Collier
1Advion BioSystems, Inc., Ithaca, NY
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Murthy Akula
3Department of Radiology, University of Tennessee, Knoxville, TN
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
George Kabalka
2Department of Radiology and Chemistry, University of Tennessee, Knoxville, TN
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Info & Metrics
Loading

Abstract

1462

Objectives The automated production of 1-[18F]fluoro-3-(2-nitro-imidazol-1-yl)-propan-2-ol ([18F]FMISO) utilizing a flow-based microfluidic chemistry system is described.

Methods The NanoTek LF is a modular flow-based microreactor assembly. The nucleophilic substitution of 1-(2’-nitro-1’-imidazolyl)-2-O-tetrahydropyranyl-3-O-p-toluenesulfonyl propanediol (NITTP; ABX Advanced Biochemical Compounds) with Kryptofix [18F]fluoride was optimized for temperature and flow rates through the reactor in the “Discovery Mode”. The optimum flow rate and temperature used for the radiosynthesis in a 100 µm i.d. X 4 m reactor were found to be 200 µl/min and 170°C respectively. This resulted in an incorporation yield of fluoride of 85 ± 3% (n= 6) as determined by radio-TLC. The intermediate THP ether obtained from the microreactor was hydrolyzed with 1 N HCl, followed by neutralization using 1 N NaOH. Final purification was performed by reverse phase semi-prep HPLC, using 4% ethanol in water (v:v).

Results 500 mCi of [18F]-Fluoride (recycled O-18 water) produced [18F]FMISO in a radiochemical yield of 40-45% (uncorr.). The total synthesis time including semi-prep HPLC purification was 50 min. The specific activity was observed to be 2 Ci/µmol with a radiochemical purity of >97%.

Conclusions Using microfluidics technology, a convenient and rapid synthesis of 1-[18F]fluoro-3-(2’-nitro-imidazol-1’-yl)-propan-2-ol was accomplished in an adequate quantity, excellent purity and high specific activity for small animal imaging studies.

Research Support The Molecular Imaging and Translational Research Progra

Previous
Back to top

In this issue

Journal of Nuclear Medicine
Vol. 51, Issue supplement 2
May 2010
  • Table of Contents
  • Index by author
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on Journal of Nuclear Medicine.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Microfluidic synthesis of [18F]FMISO
(Your Name) has sent you a message from Journal of Nuclear Medicine
(Your Name) thought you would like to see the Journal of Nuclear Medicine web site.
Citation Tools
Microfluidic synthesis of [18F]FMISO
Thomas Collier, Murthy Akula, George Kabalka
Journal of Nuclear Medicine May 2010, 51 (supplement 2) 1462;

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
Microfluidic synthesis of [18F]FMISO
Thomas Collier, Murthy Akula, George Kabalka
Journal of Nuclear Medicine May 2010, 51 (supplement 2) 1462;
Twitter logo Facebook logo LinkedIn logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One
Bookmark this article

Jump to section

  • Article
  • Info & Metrics

Related Articles

  • No related articles found.
  • Google Scholar

Cited By...

  • No citing articles found.
  • Google Scholar

More in this TOC Section

Radiopharmaceutical Chemistry: New Radiopharmaceuticals-Broader/General Applications

  • A simple preparation and evaluation of 99mTc-Dowex 1 resin: Lungs perfusion imaging agent
  • In vitro and in vivo studies of naphthylalanine derivatives in normal and diabetic mice
  • The MoRe Isotopes Project: Production of high specific activity Mo-99 via isotope separation
Show more Radiopharmaceutical Chemistry: New Radiopharmaceuticals-Broader/General Applications

New Radiopharmaceuticals-Broader/General Applications Posters

  • A simple preparation and evaluation of 99mTc-Dowex 1 resin: Lungs perfusion imaging agent
  • In vitro and in vivo studies of naphthylalanine derivatives in normal and diabetic mice
  • The MoRe Isotopes Project: Production of high specific activity Mo-99 via isotope separation
Show more New Radiopharmaceuticals-Broader/General Applications Posters

Similar Articles

SNMMI

© 2025 SNMMI

Powered by HighWire